0000950170-23-047312.txt : 20230908
0000950170-23-047312.hdr.sgml : 20230908
20230908165956
ACCESSION NUMBER: 0000950170-23-047312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230823
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund, L.P.
CENTRAL INDEX KEY: 0001783165
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 231245957
BUSINESS ADDRESS:
STREET 1: C/O ADJUVANT CAPITAL, L.P.
STREET 2: 501 FIFTH AVENUE, SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 917-334-0724
MAIL ADDRESS:
STREET 1: C/O ADJUVANT CAPITAL, L.P.
STREET 2: 501 FIFTH AVENUE, SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund DE, L.P.
CENTRAL INDEX KEY: 0001799812
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 231245956
BUSINESS ADDRESS:
STREET 1: C/O ADJUVANT CAPITAL, L.P.
STREET 2: 501 FIFTH AVENUE, SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 917-334-0724
MAIL ADDRESS:
STREET 1: C/O ADJUVANT CAPITAL, L.P.
STREET 2: 501 FIFTH AVENUE, SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adjuvant Capital GP, L.P.
CENTRAL INDEX KEY: 0001935100
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 231245955
BUSINESS ADDRESS:
STREET 1: 501 FIFTH AVENUE
STREET 2: SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 917-334-0724
MAIL ADDRESS:
STREET 1: 501 FIFTH AVENUE
STREET 2: SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adjuvant Capital Management, LLC
CENTRAL INDEX KEY: 0001935084
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 231245954
BUSINESS ADDRESS:
STREET 1: 501 FIFTH AVENUE
STREET 2: SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 917-334-0724
MAIL ADDRESS:
STREET 1: 501 FIFTH AVENUE
STREET 2: SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AN2 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001880438
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820606654
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
BUSINESS PHONE: (650) 331-9090
MAIL ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
4
1
ownership.xml
4
X0508
4
2023-08-23
0001880438
AN2 Therapeutics, Inc.
ANTX
0001783165
Adjuvant Global Health Technology Fund, L.P.
C/O ADJUVANT CAPITAL, L.P.
501 FIFTH AVENUE, SUITE 1404
NEW YORK
NY
10017
false
false
true
false
0001799812
Adjuvant Global Health Technology Fund DE, L.P.
C/O ADJUVANT CAPITAL, L.P.
501 FIFTH AVENUE, SUITE 1404
NEW YORK
NY
10017
false
false
true
false
0001935100
Adjuvant Capital GP, L.P.
C/O ADJUVANT CAPITAL, L.P.
501 FIFTH AVENUE, SUITE 1404
NEW YORK
NY
10017
false
false
true
false
0001935084
Adjuvant Capital Management, LLC
C/O ADJUVANT CAPITAL, L.P.
501 FIFTH AVENUE, SUITE 1404
NEW YORK
NY
10017
false
false
true
false
false
Common Stock
2023-09-06
4
S
false
3164
16.02
D
2180724
D
Common Stock
2023-09-06
4
S
false
598
16.02
D
412494
I
By Adjuvant Global Health Technology Fund DE, L.P.(
Common Stock
2023-09-07
4
S
false
2841
16.05
D
2177883
D
Common Stock
2023-09-07
4
S
false
537
16.05
D
411957
I
By Adjuvant Global Health Technology Fund DE, L.P.(
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.05, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.25, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
2023-09-08
Adjuvant Global Health Technology Fund DE, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
2023-09-08
Adjuvant Capital GP, L.P., By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
2023-09-08
Adjuvant Capital Management, L.L.C., By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
2023-09-08